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Macrophage Autophagy in Immunity to Cryptococcus neoformans and
Candida albicans
André Moraes Nicola,* Patrícia Albuquerque,* Luis R. Martinez,* Rafael Antonio Dal-Rosso, Carolyn Saylor, Magdia De Jesus,*
Joshua D. Nosanchuk, and Arturo Casadevall
Departments of Microbiology and Immunology and Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Autophagy is used by eukaryotes in bulk cellular material recycling and in immunity to intracellular pathogens. We evaluated
the role of macrophage autophagy in the response to Cryptococcus neoformans and Candida albicans, two important opportu-
nistic fungal pathogens. The autophagosome marker LC3 (microtubule-associated protein 1 light chain 3 alpha) was present in
most macrophage vacuoles containing C. albicans. In contrast, LC3 was found in only a few vacuoles containing C. neoformans
previously opsonized with antibody but never after complement-mediated phagocytosis. Disruption of host autophagy in vitro
by RNA interference against ATG5 (autophagy-related 5) decreased the phagocytosis of C. albicans and the fungistatic activity of
J774.16 macrophage-like cells against both fungi, independent of the opsonin used. ATG5-knockout bone marrow-derived mac-
rophages (BMMs) also had decreased fungistatic activity against C. neoformans when activated. In contrast, nonactivated ATG5-
knockout BMMs actually restricted C. neoformans growth more efficiently, suggesting that macrophage autophagy plays differ-
ent roles against C. neoformans, depending on the macrophage type and activation. Interference with autophagy in J774.16 cells
also decreased nonlytic exocytosis of C. neoformans, increased interleukin-6 secretion, and decreased gamma interferon-in-
duced protein 10 secretion. Mice with a conditionally knocked out ATG5 gene in myeloid cells showed increased susceptibility to
intravenous C. albicans infection. In contrast, these mice manifested no increased susceptibility to C. neoformans, as measured
by survival, but had fewer alternatively activated macrophages and less inflammation in the lungs after intratracheal infection
than control mice. These results demonstrate the complex roles of macrophage autophagy in restricting intracellular parasitism
by fungi and reveal connections with nonlytic exocytosis, humoral immunity, and cytokine signaling.
Cryptococcus neoformans and Candida albicans are two of themost important human-pathogenic fungi. C. neoformans is a
soil saprophyte with a worldwide distribution, whereas C. albicans
is a commensal in the human digestive tract and skin. Despite
these differences, these two microorganisms are common causes
of severe systemic infections in the vast population of immuno-
compromised individuals that results from the AIDS pandemic,
hematologic malignancies, and therapies created by modern med-
icine, such as transplantation, intravenous catheters, and immu-
nosuppressive drugs.
C. neoformans is unique among the medically important fungi
for bearing a polysaccharide capsule, which is its major virulence
attribute (50). Cryptococcosis most commonly presents as a me-
ningoencephalitis that is fatal when untreated and that kills about
20% of the patients, despite treatment with amphotericin B and
flucytosine (34). Moreover, these drugs lead to acute renal failure
in 49% to 65% of the patients (5), poignant reminders that anti-
fungal therapy is far from optimal. The global burden of crypto-
coccosis exceeds 1 million cases a year, of whom about 600,000 die
(33). The initial infection with C. neoformans, usually subclinical,
is believed to commonly occur in early childhood (11) due to
inhalation of desiccated yeast cells and spores. Upon deposition in
the lung, fungal particles are phagocytosed by alveolar macro-
phages and the yeast cells can survive within mature phagosomes.
The host response leads to the formation of granulomas contain-
ing the intracellular or extracellular yeast, which herald the state of
latency (8, 21).
C. albicans is a commensal in most humans but can cause a
wide range of diseases, especially in hosts with impaired immunity
(19). The most common ones are superficial infections of the oro-
pharyngeal, esophageal, or vaginal mucosa and skin. In the pres-
ence of risk factors such as immunosuppression, use of antibacte-
rial therapy, major abdominal surgery, or placement of venous
and urinary catheters, C. albicans cells can breach epithelial barri-
ers and reach the bloodstream, from where they disseminate to
cause invasive candidiasis with a mortality of 30 to 40% (9). Mac-
rophages are among the most important immune cells in control-
ling C. albicans cells in tissues and the bloodstream, both because
they phagocytose and kill the fungus and because they secrete
proinflammatory cytokines (47).
Autophagy is a mechanism by which cells recycle cytoplasmic
material and organelles. It is conserved through all Eukarya and
has been shown to play important roles in homeostasis and patho-
genesis (26). Several forms of autophagy are recognized, but only
macroautophagy will be dealt with in this report. This process
results in the sequestration of intracellular material inside a dou-
ble-membrane vesicle named an autophagosome. The formation
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of these vesicles requires two ubiquitin-like conjugates, one
formed by ATG5 (autophagy-related 5) and ATG12 and the other
formed by LC3 (microtubule-associated protein 1 light chain 3
alpha) and phosphatidylethanolamine (20). After their formation,
autophagosomes fuse with lysosomes, resulting in the digestion
and recycling of nutrients (26).
In addition to its role in nutritional homeostasis, autophagy
has recently been established as a mechanism of innate immunity
against viruses, bacteria, and protozoa (6). The formation of au-
tophagosomes around pathogens found in the cytoplasm, such as
Sindbis virus (22) or Listeria monocytogenes (39), leads to their
clearance by lysosomal degradation. It also allows the cell to over-
come pathogen-mediated inhibition of phagosomal maturation,
as demonstrated by the gamma interferon (IFN-)-dependent,
autophagy-mediated clearance of Mycobacterium tuberculosis
(12). A recent study found that autophagy is also involved in the
interaction between C. neoformans and macrophages (37).
Screening an RNA interference library, the autophagy genes Atg2,
Atg5, and Atg9 were each identified to be necessary for C. neofor-
mans phagocytosis and replication in and escape from Drosophila
S2 cells and murine macrophage cell lines.
Given that cryptococcosis and invasive candidiasis are inti-
mately related to the host immune status, it is important to un-
derstand how the host interacts with and controls these fungi. In
this study, we addressed the role of macrophage autophagy in this
interaction, showing that it participates in multiple steps of the in
vitro and in vivo immune response against C. neoformans and C.
albicans.
MATERIALS AND METHODS
Strains and reagents. C. neoformans var. grubii (strain H99, serotype A)
and C. albicans (strain SC5314) cultures were grown in Sabouraud
dextrose broth (Difco) at 37°C with agitation at 150 rpm for 1 to 2
days. J774.16 murine macrophage-like cells were obtained from ATCC
and cultivated in feeding medium (Dulbecco’s modified Eagle’s me-
dium supplemented with 10% fetal calf serum, 10% NCTC 109 me-
dium, and 1% nonessential amino acids) at 37°C with 10% CO2.
pEGFP-LC3 was a kind gift from Beth Levine (Dallas, TX), obtained
under permission from Noboru Mizushima (Tokyo, Japan). IgG1 mu-
rine monoclonal antibody (MAb) to cryptococcal capsular polysac-
charide 18B7 (3) was purified from hybridoma culture supernatants.
1,1-Dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate
(DiI; Vybrant DiI cell labeling solution; Invitrogen) was used at a final
concentration of 5 g/ml.
Animals. C57BL/6 mice (6- to 8-week-old females) obtained from the
National Cancer Institute (NCI) were used to obtain primary macro-
phages by peritoneal lavage. Mice with myelocyte-specific ATG5 condi-
tional knockout have been described (52) and were obtained as breeding
pairs from Herbert Virgin (St. Louis, MO). The conditional-knockout
and control mice were obtained by crossing two animals homozygous for
a flox-flanked ATG5 exon (ATG5flox) (13); one of the mice was also
heterozygous for the Cre recombinase expressed under the control of the
lysozyme gene (Lyz Cre). Pups were genotyped by PCR as previously
described (51). As the two strains used to generate the conditional-knock-
out and control mice were from two different backgrounds (129S and
C57BL/6), the resulting pups were not isogenic, and thus, all experiments
were performed with littermates. Bone marrow-derived macrophages
(BMMs) were obtained by flushing bone marrow cells from 6- to 8-week-
old male or female mice and differentiating them in Dulbecco’s modified
Eagle’s medium supplemented with 20% L929 supernatant for 7 days.
Macrophages were assayed at days 6 to 7.
Experiments with mice in this study were carried out in strict obser-
vance of Association for Assessment and Accreditation of Laboratory An-
imal Care (AAALAC) and National Institutes of Health (NIH) guidelines.
All experiments were approved by the Albert Einstein College of Medicine
Institutional Animal Care and Use Committee (IACUC).
ATG5 knockdown by shRNA lentiviral transduction. RNA interfer-
ence was used to reduce expression of ATG5, a gene that is essential for
autophagy (27). J774.16 cells were stably transduced with lentiviral vec-
tors encoding five different small hairpin RNAs (shRNAs) that target
ATG5 and one scrambled shRNA without targets in the murine genome.
Transduced cells were then selected and maintained in medium supple-
mented with 5 g/ml puromycin. Knockdown efficiency was assessed by
immunoblotting using rabbit polyclonal antibody to murine ATG5
(Santa Cruz Biotechnology), followed by detection with horseradish per-
oxidase and chemiluminescence (Thermo Scientific). Sample loading was
controlled by stripping the membranes and reprobing with mouse mono-
clonal antibody to -actin. To obtain optimal ATG5-knockdown effi-
ciency, individual transduced cells were cloned by limiting dilution, and
those ones with the lowest ATG5 expression were selected.
Macrophage-fungus interaction assays. (i) C. neoformans. Two dif-
ferent assays were used to study the interaction between C. neoformans
and macrophages. For the killing assay, described in detail elsewhere (29),
shRNA-transduced J774.16 cells were plated on 96-well tissue culture
plates at a density of 2.5  104 cells per well in feeding medium supple-
mented with or without 100 U/ml recombinant IFN- (Roche) and 500
ng/ml lipopolysaccharide (LPS; Sigma-Aldrich). After 24 h, these cells
were infected with C. neoformans cells opsonized either with MAb 18B7
(10 g/ml) to the polysaccharide capsule of C. neoformans or with mouse
serum complement (Pel-Freez) at an effector-to-target cell ratio of 1:1.
After 24 h of infection, J774.16 cells were lysed with distilled water and the
number of viable C. neoformans cells was determined by counting of the
CFU on Sabouraud dextrose agar plates after incubation at 30°C for 2
days. The second assay measured phagocytosis kinetics and was per-
formed according to a recently described method (31). Briefly, J774.16
cells and C. neoformans were independently labeled with the fluorescent
dyes 9-H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl)-succinimidyl
ester (DDAO-SE) and 5-chloromethylfluorescein diacetate (CMFDA),
respectively. After phagocytosis, the cells were incubated with the cell wall
stain Uvitex 2B (Polysciences Inc.), which stains only fungi that have not
been phagocytosed, and 7-amino-actinomycin D (7-AAD), which stains
dead macrophages. The killing assays were repeated at least four times
with at least three samples per condition each time, whereas the phagocy-
tosis assay was done once in triplicate.
(ii) C. albicans. shRNA-transduced cells were plated at 105 cells per
well in an 8-chamber polystyrene tissue culture glass slide (Becton
Dickinson) and grown overnight before use in the phagocytosis assay.
C. albicans cells were collected after 24 h of growth and washed 3 in
phosphate-buffered saline (PBS). Yeast cells were added to the macro-
phage monolayer at an effector/target cell ratio of 1:5, and the suspen-
sion was incubated at 37°C for 30 min. Cocultures were then washed
with Hank’s buffered saline solution (HBSS; pH 7.2), and the slides
were stained with 0.01% acridine orange (Sigma-Aldrich) for 45 s by
the method of Pruzanski and Saito (36). The slides were gently washed
with HBSS and stained for 45 s with 0.05% crystal violet (Sigma-
Aldrich) dissolved in 0.15 M NaCl. Finally, the slides were rinsed 3
times with PBS, mounted on microscope coverslips, and sealed at the
edge with nail polish. The phagocytic index was determined by a fluo-
rescence microscope (Axiovert 200 M inverted microscope; Zeiss). For
each experiment, the macrophages in 5 fields in each well were counted, and
at least 100 macrophages were analyzed in each well. The phagocytic index
was the ratio of the number of intracellular yeast cells to the number of mac-
rophages counted. Colony counts were made to determine the number of
viable C. albicans yeast cells after phagocytosis. For CFU determination,
shRNA-transduced and control J774.16 macrophages were infected with C.
albicans cells as described above. After 30 min of incubation, macrophages
were lysed by forcibly pulling the culture through a 26-gauge needle 5 times.
The lysates were serially diluted and plated on Sabouraud dextrose agar at
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37°C. CFU determinations were made after 48 h. Controls also consisted of
yeast cells grown without macrophages. All tests were repeated at least three
times.
Immunofluorescence microscopy. J774.16 cells or primary perito-
neal macrophages were plated on poly-L-lysine-coated 35-mm glass-
bottom plates (MatTek) and allowed to adhere for 24 h. The cell
monolayers were then infected with C. neoformans or C. albicans at
effector-to-target cell ratios of 1:1 or 1:10, and the cells were coincu-
bated for different times between 15 min and 24 h. At the desired time
interval, the cells were fixed and permeabilized with methanol at
20°C for 10 min and stained with rabbit polyclonal antibody to LC3,
followed by a fluorescein-conjugated secondary. In some experiments,
Uvitex 2B was used as well to highlight the fungal cells. After staining,
the coverslips were sealed in mounting medium (0.1 M propyl gallate
in PBS with 50% glycerol) and imaged under one of three different
microscopes: an Olympus microscope equipped with a 100 1.3-nu-
merical-aperture (NA) objective for regular epifluorescence, a Zeiss
Axioskop 200 M microscope equipped with a 63 1.4-NA objective
for regular epifluorescence and deconvolution microscopy, and a
Leica SP2 laser-scanning confocal microscope for confocal micros-
copy. The LC3 immunofluorescence microscopy experiments were re-
peated numerous times, with similar results.
Live cell imaging. J774.16 cells were transiently transfected with
pEGFP-LC3 using Lipofectamine 2000 according to the manufacturer’s
instructions. C. neoformans cells were collected from an overnight culture,
washed twice in PBS, and resuspended at 107 cells/ml in PBS containing 5
M DDAO-SE or 5-(and-6)-chloromethyl seminaphthorhodafluor ace-
tate (CM-SNARF 1). The labeling reaction was carried out overnight on
an orbital shaker at 37°C. At approximately 24 h after transfection, J774.16
cells were transferred to a glass-bottom 35-mm dish (MatTek) and incu-
bated for 24 h in Earle’s balanced salts solution (EBSS) or feeding medium
supplemented with 100 U/ml IFN- and 0.5 g/ml LPS. The plates were
then transferred to a heated-stage Perkin-Elmer UltraView RS-3 spin-
ning-disk confocal microscope in an atmosphere of humidified 5% CO2.
Labeled C. neoformans (10:1 yeast/macrophage ratio) and 10 g/ml MAb
18B7 were added immediately before imaging started. In some experi-
ments, the macrophages were loaded with the lysosomal marker 10-kDa
dextran-Texas Red (Invitrogen) between transfection with pEGFP-LC3
and infection with C. neoformans. The live-imaging experiment was re-
peated at least three times.
Image analysis. Epifluorescence images were analyzed with AxioVi-
sion (Zeiss), ImageJ, and Photoshop software. Epifluorescence z stacks
were deconvolved with a constrained iterative algorithm with AxioVision.
Spinning-disk confocal image sets were manipulated on ImageJ and Pho-
toshop software. Images were collected in color on an Olympus micro-
scope; all other images were collected in gray scale and pseudocolored
later. All spinning-disk confocal images were enhanced for contrast and
brightness to highlight the weak signal.
Transmission electron microscopy. J774.16 cells were grown on
6-well tissue culture dishes for 24 h and infected with C. neoformans at a
1:1 effector-to-target cell ratio in the presence of 10 g/ml 18B7. After
12 h, the cells were fixed with 2.5% glutaraldehyde in 0.1 M sodium caco-
dylate buffer, postfixed with 1% osmium tetroxide followed by 2% uranyl
acetate, dehydrated through a graded series of ethanol, and embedded in
LX112 resin (LADD Research Industries, Burlington, VT). Ultrathin sec-
tions were cut on a Reichert Ultracut UCT ultramicrotome, stained with
uranyl acetate followed by lead citrate, and viewed on a JEOL 1200EX
transmission electron microscope at 80 kV.
Quantification of nonlytic exocytosis by flow cytometry. Nonlytic
exocytosis of C. neoformans was quantified using a flow cytometric
method as described previously (31). Briefly, J774.16 and C. neoformans
cells were each independently labeled with the cell tracking dyes
DDAO-SE and CMFDA, respectively, and coincubated for 2 h. The
monolayer was then stained with Uvitex 2B and 7-AAD, followed by flow
cytometric sorting of macrophages with internalized fungi. The sorted
cells were incubated for 24 h and then analyzed by flow cytometry again to
determine the percentage of macrophages that underwent nonlytic exo-
cytosis. The results from multiple experiments were pooled for statistical
analysis, as done before (2, 24, 29).
Murine survival experiments. (i) C. neoformans. For intraperitoneal
infection, 500 l of C. neoformans suspension containing 105 to 107 cells of
strain H99 cells in PBS was injected in the peritoneal cavity. For intratra-
cheal infections, mice were anesthetized with 100 mg/kg of body weight
ketamine and 10 mg/kg of body weight xylazine. An incision was made on
the neck, and 50 l of C. neoformans suspensions containing 2.5  104 to
106 C. neoformans strain H99 in PBS was injected into the trachea using a
250-l glass syringe and a 26-gauge needle. The incision was closed using
veterinary adhesive (Vetbond; 3M). For survival studies, infected mice
were inspected daily and euthanized by CO2 inhalation in case of distress.
Each survival experiment had at least 10 littermate mice of the same sex
and age per group.
(ii) C. albicans. For survival studies, mice were infected by inoculation of
5  105 C. albicans cells in the tail vein and inspected daily. The experiment
was performed with 10 littermate female mice (age, 6 to 8 weeks) per group.
Lung and brain fungal burden. ATG5-conditional-knockout and con-
trol littermate mice were infected intratracheally with 105 C. neoformans
strain H99 cells and euthanized 3, 7, and 14 days later. Their lungs and brains
were removed and homogenized in sterile PBS. The homogenates were seri-
ally diluted and plated on Sabouraud agar. After incubation for 2 days at 30°C,
the number of colonies was counted and multiplied by the dilution to deter-
mine the number of CFU. There were five female mice aged 6 to 8 weeks per
group per time interval.
Quantification of cytokines. Samples were prepared for cytokine
quantification using a multiplexed microsphere assay (Luminex, Austin,
TX) and a kit with reagents for 22 cytokines and chemokines: granulocyte
colony-stimulating factor, granulocyte-macrophage colony-stimulating
factor, IFN-, interleukin-10 (IL-10), IL-12 (p70), IL-13, IL-15, IL-17,
IL-1, IL-1, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IFN--induced protein 10
(IP-10), keratinocyte-derived cytokine, monocyte chemoattractant pro-
tein 1, macrophage inflammatory protein 1 (MIP-1), RANTES, and
tumor necrosis factor alpha (TNF-) (Millipore, Billerica, MA). The first
sample to be quantified was prepared by plating the control and ATG5
shRNA-transduced J774.16 cells on petri dishes and infecting with C.
neoformans strain H99 opsonized with 10 g/ml 18B7 for 24 h at a 1:10
macrophage/C. neoformans ratio. The supernatant was then collected,
centrifuged, filtered, supplemented with a cocktail of protease inhibitors
(Roche), and frozen until analyzed. The analysis was performed with su-
pernatants from three independent experiments. The other samples were
lung homogenates from the day 14 fungal burden assay described above;
immediately after plating for determination of the numbers of CFU, a
cocktail of protease inhibitors was added to the homogenates and they
were frozen until analyzed. The analysis was performed with lung homog-
enates from five mice per group.
Histology. ATG5-conditional-knockout and control mice were eu-
thanized by CO2 inhalation and exsanguination at 3, 7, and 14 days
after intratracheal infection with 105 C. neoformans strain H99 cells.
Five littermate females aged 6 to 8 weeks per group per time point were
used. The lungs, spleen, liver, and brain were dissected, fixed in 10%
neutral formalin, routinely processed to paraffin, sectioned (5 m),
and stained with hematoxylin-eosin. Samples for immunohistochem-
istry (IHC) were sectioned to a thickness of 5 m and deparaffinized in
xylene followed by graded alcohols. Antigen retrieval was performed in
10 mM sodium citrate buffer at pH 6.0, heated to 96°C, for 30 min.
Endogenous peroxidase activity was blocked using 0.3% hydrogen
peroxide in water. The sections were stained by routine IHC methods
with the primary antibody to Ym-1 (R&D Systems, Minneapolis, MN),
followed by horseradish peroxidase-conjugated mouse IgG secondary
antibody. The antibody binding was detected using an avidin-biotin-
horseradish peroxidase system, followed by the use of diaminobenzi-
dine as the chromogen. All immunostained sections were lightly coun-
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terstained with hematoxylin. Both hematoxylin-eosin and IHC slides
were evaluated semiquantitatively by a board-certified veterinary pa-
thologist.
Statistical analysis. The results of the in vitro experiments with mac-
rophages and the fungal burden and cytokine quantification assays were
compared by two-way analysis of variance (ANOVA) using GraphPad
Prism software (GraphPad Software Inc., La Jolla, CA). Nonlytic exocy-
tosis results were compared by two-tailed chi-square test with Yate’s cor-
rection (GraphPad Software Inc.). Survival in murine infection studies
was compared by log-rank (Mantel-Cox) test using GraphPad Prism soft-
ware. Results from multiple survival studies were evaluated with Cox pro-
portional hazards regression using IBM SPSS software.
RESULTS
Reduction in autophagy alters antifungal activity of macro-
phages. To determine whether autophagy is involved in macro-
phage immunity against fungi, we reduced ATG5 expression with
RNA interference. This was achieved with stable transduction of
lentiviral vectors in J774.16 cells with shRNAs that targeted differ-
ent regions of the ATG5 gene. J774.16 clones transduced with
three of these shRNAs, with ATG5 expression levels of 25% to
63% compared with the control (Fig. 1A), were infected with C.
albicans or C. neoformans to assess phagocytosis and killing of the
pathogens. We found no significant effect of ATG5 knockdown in
phagocytosis of C. neoformans after 2 h of coincubation (Fig. 1B)
but observed significantly decreased phagocytosis of C. albicans
after 30 min of coincubation (Fig. 1C). A series of CFU experi-
ments was then done to evaluate C. neoformans killing. At 24 h
after incubation, ATG5 knockdown in J774.16 cells resulted in a
dose-dependent decrease of fungistatic activity against both anti-
body (Ab)- and complement-opsonized C. neoformans (Fig. 1D
FIG 1 Lack of ATG5 decreases phagocytosis and intracellular killing of C. neoformans and C. albicans. (A) Two different shRNA sequences targeting murine
ATG5 were transduced into J774.16 cells (clones 30 and 31), as was a scrambled shRNA control (C). After selection with puromycin and cloning, J774.16 clones
were evaluated by immunoblotting for ATG5 and -actin expression. The proportion of ATG5 expression in comparison with the scrambled shRNA control was
calculated by densitometry, and the two clones with the highest knockdown efficiency were selected for further experiments. (B) Antibody-opsonized C.
neoformans phagocytosis after 2 h of coincubation using ATG5 shRNA-transfected J774.16 cells. The y axis represents the percentage of total macrophages with
internalized C. neoformans cells. Bars represent the means of three independent experiments. (C) C. albicans phagocytosis after 30 min of coincubation with
ATG5 shRNA J774.16 cells. The y axis represents the phagocytic index, calculated by dividing the number of internalized fungal cells by the total number of
macrophages. Bars represent the means of five independent experiments. (D and E) C. neoformans killing assays after 24 h of incubation with ATG5 shRNA-
transfected J774.16 cells. Monoclonal antibody and serum complement were used as opsonins in panels D and E, respectively. Bars represent the means and SEMs
of 4 to 16 independent experiments. (F) C. albicans killing assay after 30 min of coincubation with ATG5 shRNA-transfected J774.16 cells. Bars represent the
means and SEMs of 3 independent samples. (G and H) Secretion of IL-6 and IP-10 by shRNA-transfected cells. Each clone was incubated for 24 h with or without
antibody-opsonized C. neoformans, and the supernatants were used for cytokine quantification. Bars represent the means and SEMs of 3 independent samples.
*, P  0.05 on the Bonferroni posttest that followed ANOVA analyses.
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and E). At 2 h of coincubation, there was no significant difference
in the number of CFU independent of the activation status (data
not shown). The C. albicans killing assays could not be done with
long coincubation times because filamentation made it impossible
to count fungal cells. However, after 30 min of coincubation we
observed a significant reduction in the ability of J774.16 cells to kill
C. albicans (Fig. 1F).
To confirm the results obtained with J774.16 cells with primary
cells, BMMs were isolated from ATG5-conditional-knockout and
littermate control mice. These macrophages efficiently restricted
growth of Ab- and complement-opsonized C. neoformans, and
their anticryptococcal activity was enhanced by IFN- and LPS
stimulation. In contrast to the result obtained with ATG5 shRNA
J774.16 cells, nonactivated BMMs showed better killing of C. neo-
formans when ATG5 was knocked out. Upon activation, however,
a higher number of CFU was recovered from ATG5-knockout
macrophages infected with complement-opsonized but not those
infected with Ab-opsonized C. neoformans (see Fig. S1 in the sup-
plemental material).
In short, the effect of autophagy on macrophage antifungal
activity depended on the opsonin, macrophage type, and activa-
tion state. In J774.16 cells, autophagy knockdown decreased
phagocytosis and killing of C. albicans and fungistasis of both
complement- and antibody-opsonized C. neoformans. In nonac-
tivated BMMs, autophagy knockout increased fungistasis of C.
neoformans, whereas in activated BMMs, autophagy knockout de-
creased antifungal activity.
Autophagy knockdown alters the cytokine response to C.
neoformans. Our next step was to study the role of autophagy on
secretion of cytokines, both on macrophages alone and on mac-
rophages infected with C. neoformans. The shRNA-transduced
J774.16 cells were cultivated with or without antibody-opsonized
C. neoformans for 24 h, and the supernatants were collected to
quantify 22 different cytokines and chemokines (see Table S1 in
the supplemental material). J774.16 cells transduced with two dif-
ferent shRNAs targeting ATG5 secreted more IL-6 after infection
with C. neoformans (Fig. 1G). An opposite trend was observed
with the chemokine IP-10 (CXCL-10), which was significantly
reduced in the supernatants of ATG5 shRNA cells, both with and
without C. neoformans infection (Fig. 1H).
Phagosomes containing fungi have the autophagy-specific
marker LC3. After observing that autophagy contributed to fun-
gistasis and cytokine secretion, we studied the mechanisms that
could be involved in this process. Initially, we infected both
J774.16 cells and primary macrophages with C. neoformans or C.
albicans and performed immunofluorescence against LC3, a spe-
cific autophagosome marker (18). These experiments revealed
that after Ab-mediated phagocytosis, some of the C. neoformans
phagosomes became autophagosomes in J774.16 cells (Fig. 2A)
and in primary macrophages (see Fig. S2A in the supplemental
material). A control experiment performed with J774.16 cells in
which the LC3 antibody was omitted (Fig. 2B) showed that the
LC3-positive phagosome was not an artifact caused by direct
binding of the secondary antibody. Kinetic experiments revealed
that autophagosome formation could be observed at as early as 30
min and as late as 24 h after infection but was most frequently
observed at about 12 h after infection (data not shown). At 12 h
after infection with Ab-opsonized C. neoformans, 36 of 44 (82%)
macrophages with internalized C. neoformans contained the fungi
in LC3-positive phagosomes. Of note, we did not observe LC3-
positive phagosomes in 54 of the J774.16 cells infected with com-
plement-opsonized C. neoformans at 12 h postinfection (Fig. 2C).
To understand how the autophagosome was formed, J774.16
cells were transiently transfected with enhanced green fluorescent
protein (EGFP)-tagged LC3 for live imaging of C. neoformans
phagocytosis. These movies confirmed with a different methodol-
ogy that autophagosomes formed around C. neoformans hours
after infection and suggested that LC3 was recruited by sequential
fusion of small autophagosomes with the C. neoformans vacuole
(Fig. 2D; see Movie S1 in the supplemental material). In addition,
inclusion of the endosomal marker 10-kDa dextran-Texas Red
suggested that this structure was formed after fusion of lysosomes
with the C. neoformans vacuole and that the small autophago-
somes that fused were not autophagolysosomes (see Fig. S2B in
the supplemental material).
Transmission electron microscopy was used to search for ul-
trastructural hallmarks of autophagy such as vesicles with double
membranes. We imaged J774.16 cells 12 h after infection with C.
neoformans, as this was the time when autophagosomes were more
frequent (see Fig. S2C in the supplemental material). Addition-
ally, we examined archival transmission electron microscopy im-
ages collected from the lungs of C. neoformans-infected mice from
a previous study (10) (data not shown). We did not observe au-
tophagosome hallmarks such as double membranes surrounding
fungal cells or undigested cytosolic contents inside the C. neofor-
mans vacuole in any of these experiments. Instead, consistent with
the live-imaging results, we observed double-membrane vesicles
in close proximity to and fusing with the C. neoformans vacuole.
In contrast, in J774.16 cells infected with C. albicans for 2 h,
most fungal cells were contained in LC3-positive vacuoles (Fig.
3A). The autophagosome marker could be found surrounding
both yeast and hyphal forms of the fungus. Two negative-con-
trol experiments confirmed that the observed signal came from
macrophage LC3 surrounding the fungal cells (Fig. 3B). Later
experiments showed that LC3 is recruited to phagosomes con-
taining C. albicans at all time points tested between 15 min and
24 h, with occasional images suggesting that even C. albicans
cells that were not fully phagocytosed were already LC3 posi-
tive (see Fig. S3A in the supplemental material). Surprisingly,
we observed that some C. albicans cells that were clearly not
internalized or even in close proximity to macrophages were
nevertheless LC3 positive (see Fig. S3B in the supplemental
material).
Thus, in C. albicans-infected macrophages, LC3 is recruited to
the membranes of most phagosomes shortly after phagocytosis. In
contrast, in C. neoformans-infected macrophages, the recruitment
of LC3 takes a longer time, happens in only a fraction of the in-
fected macrophages, and depends on the opsonin, as only anti-
body-opsonized fungi end up in LC3-positive vacuoles.
Autophagy knockdown reduces C. neoformans nonlytic
exocytosis. During the epifluorescence and live-imaging experi-
ments, we observed C. neoformans cells that were not inside mac-
rophages but were surrounded by a layer of LC3-containing ma-
terial after infection of both J774.16 cells (see Fig. S4A in the
supplemental material) and primary murine macrophages
(data not shown). To ascertain the validity and reproducibility
of this observation, we infected J774.16 cells with antibody-
opsonized C. neoformans in a tissue culture dish, washed the
noningested fungi after 2 h, and 24 h after infection collected
the supernatant, which should be enriched with fungal cells
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that had been exocytosed. Half of these cells were fixed in cold
methanol, and both fixed and nonfixed samples were stained
with LC3 antibody, showing that LC3 surrounded cells in both
samples. Additionally, some cells were also stained with the
lipophilic probe DiI, previously shown to stain lipid bilayers
outside the C. neoformans cell wall (30). None of the LC3 layers
in either fixed or nonfixed cells stained with DiI (data not
shown), suggesting that those structures contained the LC3
protein but not a lipid bilayer. To exclude the possibility of
nonspecific binding of antibodies to C. neoformans, an aliquot
of the fungal cells that were used for infection was stained and
imaged under identical conditions, without any observable
fluorescence surrounding the cells (see Fig. S4B in the supple-
mental material). A similar observation is apparent at the end
of a movie in which we captured the autophagosome formation
(see Fig. S4C and Movie S2 in the supplemental material): after
accumulation of EGFP-LC3 around the C. neoformans cells,
they were expelled from the cytoplasm of the macrophage to
the medium. This movie probably does not depict a genuine
nonlytic exocytosis event, though, because the J774.16 cell ap-
FIG 2 Phagosomes containing C. neoformans acquire LC3. (A) LC3 localization in J774.16 cells infected with antibody-opsonized C. neoformans for 12 h. (B)
Negative control done in parallel with the images shown in panel C. The samples were processed and imaged identically, except for the exclusion of the LC3
antibody. (C) Effect of the opsonin on LC3 localization in J774.16 cells infected with C. neoformans for 12 h. (D) Montage of time-lapse images of EGFP-LC3-
tranfected J774.16 cells infected with C. neoformans. From the top left, each frame represents a single slice through the center of the cell, with an interval between
each image of 24 min. The complete time-lapse series is included in Movie S1 in the supplemental material. (A to C) z-stack projections of stacks collected on a
Leica SP2 point-scanning microscope. LC3 (green) was labeled by immunofluorescence, and the cell wall (blue) was labeled with Uvitex 2B. DIC, differential
interference contrast. Bars, 10 m.
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peared to be dead at the end, likely due to phototoxicity and
incubation in EBSS with no serum or nutrients. Together with
our serendipitous observations during the LC3 immunolocal-
ization studies, this led us to hypothesize that autophagy was
involved in nonlytic exocytosis, and we examined whether au-
tophagy knockdown altered the rate of nonlytic exocytosis. Us-
ing flow cytometry to measure nonlytic exocytosis as we re-
cently described (31), two of the ATG5-knockdown J774.16
strains had 10% to 20% decreased rates of nonlytic exocytosis
of C. neoformans compared to the control cells (Table 1).
Infection of mice with conditional knockout of macrophage
autophagy. To evaluate the in vivo significance of the results that
we achieved with in vitro studies, we used murine models of cryp-
tococcosis and systemic candidiasis with conditional knockout of
ATG5 in macrophages. These knockout mice died faster than con-
trols when infected intravenously with C. albicans (Fig. 4A). Ex-
periments with C. neoformans were done using two different
routes of infection (intraperitoneal and intratracheal), different
inocula (from 2.5  104 to 106 C. neoformans cells per mouse), and
mice at different ranges of age and sex, but no statistically signifi-
cant differences were found (see Fig. S5 in the supplemental ma-
terial). Even when the results of all C. neoformans survival exper-
iments were combined using Cox proportional hazards
regression, there was no significant difference in survival between
the two strains (Fig. 4B).
To further investigate the reason why there was no difference
in murine survival despite the fact that autophagy-negative mac-
rophages were less able to contain C. neoformans, we measured
fungal burden, cytokine expression, and tissue inflammation in
infected mice. We chose the intratracheal route with an inoculum
of 105 C. neoformans cells; under these conditions, mice start dying
16 days after infection, so the evaluations were done at 3, 7, and 14
days. C. neoformans burdens at the primary infection site, lungs,
and at the target organ, brain, were quantified by CFU enumera-
tion. At all three times evaluated, the numbers of CFU in the lungs
were lower in the ATG5-conditional-knockout mice, and this dif-
ference was statistically significant when analyzed by linear regres-
sion (Fig. 4C). On the other hand, the brain fungal burden showed
no statistically significant difference (P 	 0.05). On day 14, in
addition to CFU counting, we used the lung homogenates to
quantify cytokines and chemokines (see Table S2 in the supple-
mental material). ATG5-conditional-knockout mice had lower
concentrations of IL-4, IL-13, MIP-1, and IP-10 in the lung ho-
mogenates than control mice (Fig. 4D).
We also evaluated the histology of cryptococcal intratracheal
infection in ATG5-conditional-knockout and control mice
(Fig. 5A to C). In both groups of mice, spleens and livers had no
notable findings. The brains had lesions only at day 14. The
most striking findings were in the lungs of infected mice, with a
marked difference between ATG5-conditional-knockout and
control mice. Differences in the lung lesions on day 3 were
limited, although only 2 of 5 ATG5-conditional-knockout
mice had pyogranulomatous inflammation with intralesional
FIG 3 Phagosomes containing C. albicans acquire LC3. (A) LC3 localization in J774.16 cells infected with C. albicans for 2 h. (B) Negative controls done in
parallel with the images shown in panel A. The images show samples that were processed and imaged exactly like those in panel A, but with two differences. On
the left-side images, the LC3 antibody was omitted to test if the secondary antibody recognized nonspecifically any macrophage structure. The right-side images
show C. albicans cells that were incubated without macrophages and stained with the LC3 and secondary antibodies to test if the antibody recognized C. albicans.
The controls show autofluorescent cells but not the bright LC3 layer surrounding the internalized C. albicans. LC3 (green) was labeled by immunofluorescence,
and all images were collected by epifluorescence on a Zeiss microscope. Bars, 10 m.
TABLE 1 ATG5 shRNA decreases nonlytic exocytosis of C. neoformans
Clone
No. of cells
%
exocytosis P valueaTotal Exocytosed
Clone 31 86,116 41,445 48 0.001
Cb 102,459 61,123 60
Clone 30 80,568 49,671 62 0.001
C 54,582 37,581 69
a P values were calculated by Fisher’s exact test with the Yates correction. Results were
pooled from two independent experiments with clone 30 and three independent
experiments with clone 31.
b C, scrambled shRNA control.
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C. neoformans, whereas 4 of 5 ATG5 control mice had such
lesions. On day 7, small tan-red lesions appeared in the lungs of
most mice from both groups upon gross inspection. While 5 of
5 ATG5-conditional-knockout mice but only 3 of 5 control
mice had pyogranulomatous inflammation, the inflammation
in the knockout mice was less severe and contained notably
fewer neutrophils than that in the control animals. On day 14,
the gross pulmonary lesions in the controls grew to large trans-
lucent nodules, whereas the small tan-red lesions in ATG5-
conditional-knockout mice were mostly unchanged (Fig. 5D).
Histologically, the amount of airspace free of inflammation
and/or C. neoformans cells in the ATG5-conditional-knockout
animals was, on average, nearly double that in the control mice
(48% versus 28%, respectively). Control mice, therefore, had
more significant pulmonary disease than the ATG5-condition-
al-knockout mice. Control mice also had greater perivascular
lymphocytic cuffing (moderate), generally a reflection of the
severity of acute lung inflammation, than ATG5-conditional-
knockout animals (minimal).
Together, the results of the experimental cryptococcosis models
suggested that knocking out ATG5 in macrophages could alter the
balance of classical and alternative activation of macrophages. To test
this hypothesis further, lung sections taken from mice infected 3 and
14 days before were used for immunohistochemistry with an anti-
body to Ym-1, a chitinase family protein that is specifically produced
by macrophages activated by Th2 cytokines (38). On day 3, several
foci of Ym-1-positive cells were visible in the lungs from control mice,
whereas foci were rare in the ATG5-conditional-knockout mice. On
day 14, there was no difference between the two groups of mice, with
both presenting intense labeling throughout the lung (Fig. 5E).
FIG 4 ATG5-conditional-knockout increases murine mortality due to candidiasis but not cryptococcosis. (A) Mouse survival experiment after intravenous C.
albicans infection. Each group had 10 mice. (B) Cox proportional hazards regression combining the results of seven survival experiments with mice infected with
C. neoformans using different routes and inocula. No statistically significant difference in survival was observed in any individual experiment (see Fig. S5 in the
supplemental material) or when the data from all animals (84 per group) were combined. (C) Lung and brain fungal burdens of ATG5-conditional-knockout
mice infected intratracheally with 105 C. neoformans cells. Samples were collected from five mice per group at each time interval (3, 7, and 14 days after infection).
(D) Lung cytokine quantification. The four cytokines with statistically significant differences in concentration in the lung homogenates are shown. Bars represent
means and SEMs. *, P  0.05 in the Bonferroni posttest that followed a two-way ANOVA.
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In conclusion, infection of ATG5-conditional-knockout mice
with C. albicans results in decreased survival, whereas C. neofor-
mans infections result in no difference in survival. However,
ATG5-conditional-knockout mice have decreased lung fungal
burden, decreased lung cytokines (IL-4, IL-13, MIP-1 and IP-
10), less intense pyogranulomatous pneumonia, and delayed al-
ternative activation of macrophages.
DISCUSSION
The importance of autophagy in the response against intracellular
pathogens has been recognized by studies that have used a broad
variety of viral, bacterial, and protozoan pathogens to uncover the
diverse roles of autophagy mechanisms as effectors and regulators
of innate and adaptive immunity (6). Our results indicate the
FIG 5 ATG5 conditional knockout alters the murine immune response to intratracheal C. neoformans infection. (A to C) Histology of the lungs of ATG5-
conditional-knockout and control mice 3, 7, and 14 days after intratracheal infection with 105 C. neoformans cells. Hematoxylin-eosin-stained sections were
evaluated semiquantitatively by a veterinary pathologist. Five mice were used per group per time interval. (A) The arrow points to a reactive vessel. (B) The arrows
point to infiltrated neutrophils with dense polymorphic nuclei and scant cytoplasm, whereas the arrowheads indicate infiltrated macrophages with round nuclei
and large cytoplasm. (C) The arrowheads point to alveoli that are not occupied by C. neoformans or inflammatory cells in the lungs of conditional-knockout mice.
(D) Macroscopic appearance of the lungs from 3 ATG5-conditional-knockout mice and 3 control mice infected with C. neoformans for 14 days showing large
translucent nodules in the controls and smaller tan-red nodules in the ATG5-conditional-knockout animals. (E) IHC localization of Ym-1, a marker of
alternatively activated macrophages, on lung sections from days 3 and 14. The arrows point to clusters of alternatively activated macrophages on the lungs of
control mice infected with C. neoformans for 3 days. Bars, 500 m (images at 2.5 and 4 magnifications) and 50 m (images at 40 magnification).
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involvement of autophagy mechanisms in cellular and host de-
fense against the fungal pathogens C. neoformans and C. albicans,
with the caveat that their effects appear to be dependent on the
fungal species, macrophage type, opsonin, and activation state.
The key experiments described in this report are summarized in
Table S3 in the supplemental material.
Our first experiment established the involvement of autophagy
by disrupting the autophagic machinery, followed by evaluating
its effects on the ability of macrophages to phagocytose fungi and
kill or restrict their intracellular growth. In vitro experiments with
J774.16 cells were done using RNA interference instead of phar-
macological autophagy inhibitors because these drugs could also
inhibit the pathogen’s own autophagic machinery, which is dis-
pensable for C. albicans survival in macrophages (32) but neces-
sary for C. neoformans virulence (16). Infection of J774.16 cells
transduced with shRNA revealed that control cells efficiently
phagocytosed and killed C. albicans, whereas those with decreased
autophagy were less able to ingest and control the pathogen. These
results suggest that the macrophage response against C. albicans is
mediated in part by autophagy. The experiments with C. neofor-
mans, on the other hand, had more complex results. With J774.16
cells, interference with autophagy did not alter phagocytosis but
significantly decreased fungistatic activity. This result contrasts
with the previous report of an approximately 25% reduction in
intracellular replication of C. neoformans in macrophages with
siRNA against ATG5 (37), perhaps due to differences in the mac-
rophage cell line used (J774.16 versus RAW264.7), in the method-
ology used to measure macrophage antifungal activity (killing as-
say versus fluconazole protection assay), or in the multiplicity of
infection (1:1 versus 1:10, macrophages/C. neoformans cells).
With BMMs, the effect of ATG5 knockout in fungistatic activity
was dependent on the activation of macrophages. Nonactivated
ATG5-knockout BMMs were less permissive to fungal growth, as
described for RAW264.7 cells. In contrast, when the BMMs were
activated by IFN- and LPS, the lack of ATG5 made them more
permissive to fungal growth. These results suggest that macro-
phage activation might increase antifungal activity by inducing
autophagy, as has been described with M. tuberculosis (12).
Having shown that autophagy has a function in the response of
macrophages to C. neoformans and C. albicans, we localized the
autophagy marker LC3 on infected J774.16 cells. We observed that
in some of the J774.16 cells containing C. neoformans, the fungal
phagosome contained LC3. These LC3-positive C. neoformans
vacuoles were observed at as early as 30 min after infection but
were more easily observed at later times of infection. Qin et al. also
observed LC3-positive phagosomes containing C. neoformans in
40 to 60% of infected J774.A1 cells; however, they reported a faster
kinetics, with a peak of LC3 positivity 3 h after infection, some-
what before the acquisition of the lysosomal marker LAMP-1 (37).
Our data with the lysosomal marker dextran-Texas Red suggest
that LC3-positive vacuoles are formed after phagolysosomal fu-
sion. Transmission electron microscopy and live imaging with
EGFP-tagged LC3 confirmed that this marker was acquired by
sequential fusion with small LC3-positive vesicles and not by a de
novo formation of a double-membrane autophagosome. In con-
trast to what was observed with C. neoformans, most C. albicans
phagosomes were LC3 positive shortly after and apparently even
during phagocytosis. A similar pattern of fast LC3 recruitment was
reported for phagocytosis of zymosan particles (40). This work
also showed that LC3 recruitment was mediated by recognition of
the zymosan by Toll-like receptor 2 (TLR2), a pattern recognition
receptor that recognizes C. albicans cell wall components (48).
Our results thus suggest that LC3 recruitment to the C. albicans
phagosome might be mediated by recognition of pathogen-asso-
ciated molecular patterns leading to increased clearance of the
fungus. TLR2, however, is probably of little importance in C. neo-
formans infection because the polysaccharide capsule masks rec-
ognition of cell wall components (28, 49). Consequently, the dif-
ferential recognition by TLR2 could explain why phagosomes
containing C. albicans acquire LC3 immediately, whereas the ones
containing C. neoformans do not.
As C. neoformans is not phagocytosed by macrophages unless
an opsonin is present, we were able to dissect the effects of au-
tophagy on pathogens that were internalized by antibody- or com-
plement-mediated phagocytosis. In C. neoformans killing assays
using both types of autophagy-deficient macrophages, we ob-
served that the effect of autophagy knockdown on fungistatic ac-
tivity was more pronounced upon complement opsonization than
in the presence of antibody. However, we never observed LC3-
positive C. neoformans-containing vacuoles in multiple experi-
ments in which the fungi were opsonized with complement. Mu-
rine IgG1, such as the one used in this work, mediates
phagocytosis of C. neoformans mostly via Fc receptor III (41) or
complement receptor 3 (CR3), even in the absence of complement
(44). In contrast, capsule-bound complement fragment C3b
mostly interacts with CR3 (4). These receptors have different
downstream effectors, so the absence of LC3 in phagosomes con-
taining complement-opsonized C. neoformans and in a fraction of
those containing antibody-opsonized fungi suggests an inhibitory
signal from CR3 engagement with regard to the recruitment of the
autophagy machinery.
Taken together, these results show that in vitro macrophage
autophagy is important in immunity against C. neoformans and C.
albicans. For some pathogens that escape into the cytoplasm, au-
tophagy works by pathogen encasement inside membranes that
can then be fused with lysosomes for degradation (22, 39). C.
neoformans and C. albicans, however, remain inside a vacuole. For
other pathogens, such as Mycobacterium tuberculosis (12), encas-
ing the bacterium inside autophagosomes helps the host cell over-
come pathogen-driven blockage of phagosomal maturation, acid-
ification, and fusion with lysosomes. This must not be the case
here, as the C. neoformans vacuole matures rapidly (21) and mat-
uration should be complete by the time that fusion with autopha-
gosomes starts. Instead, fusion with autophagosomes could de-
liver a toxic payload, as described for M. tuberculosis (1). In that
work, the authors purified autophagosomal contents and detected
mycobactericidal peptides derived from digested ubiquitin. Re-
cent studies with M. tuberculosis expanded the notion of autopha-
gosomal delivery of antimicrobial peptides, which are derived
from ribosomal protein S30 (also known as ubiquicidin) and
polyubiquitinated proteins targeted to autophagosomes by the
adaptor p62 (35). One of the antimicrobial peptides described by
these authors as being active against M. tuberculosis, ubiquicidin,
has also been shown to affect C. albicans (46). It is thus feasible that
autophagy inhibits antibody-opsonized C. neoformans by engulf-
ing and digesting intracellular material that is then delivered to the
fungal vacuole, leading to the accumulation of antifungal pep-
tides. An additional possibility is that the antifungal mechanism
affected by interference with ATG5 is autophagosome indepen-
dent, such as that described for Toxoplasma gondii (51). Lack of
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macrophage ATG5 impaired IFN--mediated recruitment of the
Irga6 GTPase to the parasitophorous vacuole, resulting in de-
creased immunity to T. gondii. This effect happened in spite of the
fact that no LC3 was recruited to the parasitophorous vacuole,
suggesting a possible explanation for our observations with com-
plement-opsonized C. neoformans.
Besides phagocytosis, macrophages have other important ac-
tivities in immunity to fungi. These phagocytes secrete cytokines
and chemokines that attract other cells of the immune system and
modulate their action. Autophagy has extensive links with cyto-
kine signaling, being induced by proinflammatory cytokines such
as IFN-, TNF-, and IL-1 and inhibited by anti-inflammatory or
Th2-type cytokines such as IL-4, IL-10, and IL-13. Autophagy also
controls the production and secretion of IL-1, IL-18, TNF-, and
type I IFN (14). With this in mind, we tested the production of 22
cytokines and chemokines by ATG5 shRNA-transduced J774.16
cells both with and without infection with C. neoformans. Au-
tophagy-deficient cells secreted more IL-6, a cytokine that has
been shown to augment macrophage activity against C. neofor-
mans (43). This result could be interpreted as an autocrine loop
circumventing the decreased antifungal activity of the macro-
phage. Interference with ATG5 also decreased secretion of IP-10,
which was observed in the two clones of shRNA-transduced
J774.16 cells both with and without infection. IP-10 was also re-
duced in the lungs of ATG5-conditional-knockout mice 14 days
after infection with C. neoformans. These two very different exper-
imental situations nevertheless point to a specific role for ATG5 in
secreting this chemokine. This result agrees with a previous report
that treating the murine intestinal epithelial cell line Mode-K with
the autophagy inhibitor 3-methyladenine decreased IP-10 secre-
tion by inhibiting the secretion of vesicles containing the chemo-
kine (15). IP-10 is a chemokine secreted by monocytes, fibro-
blasts, and epithelial and endothelial cells, among others, and
increases chemotaxis of monocytes/macrophages and natural
killer, dendritic, and T cells (23). It is also involved in orchestrat-
ing neutrophilic pneumonia (25), so the reduction in IP-10 could
explain the decreased neutrophilic infiltrates that we observed in
the ATG5-conditional-knockout mice.
We explored whether macrophage autophagy was involved in
nonlytic exocytosis of C. neoformans from macrophages based on
the serendipitous finding that some extracellular C. neoformans
cells were covered in an LC3-positive layer. This observation sug-
gested that these cells were once contained in an autophagosomal
compartment and had retained LC3 upon their exit from the host
cells. Control experiments demonstrated that this LC3 cover was
derived from the macrophage, as the fungal protein was not rec-
ognized by the LC3 antibody. This observation resembles the
mechanism of nonlytic release of poliovirus that hijacks cellular
autophagosomes to assemble the machinery that mounts viral
particles (42). Assembled virions are encased by autophagosomes
which fuse with the cytoplasmic membrane, releasing viruses in-
side an LC3-positive vesicle without lysing the host cell (17). To
test if this was the case, we stained exocytosed C. neoformans cells
with LC3 antibody and the membrane probe DiI. However, none
of the LC3-positive layers bound the probe, suggesting that only
LC3 protein and not autophagosome membranes remained in
exocytosed fungi. Subsequent measurements of nonlytic exocyto-
sis in the ATG5 shRNA-transfected J774.16 cells showed that au-
tophagy is indeed involved in this phenomenon. A similar finding
was also reported by Qin et al. (37). Using a fluconazole protection
assay to measure escape of C. neoformans cells from RAW264.7
macrophages, they have shown that transfection with siRNA
against ATG5 decreased escape by about 25% (37). Autophagy is
also involved in other instances of nonlytic release of lysosomal
contents. In microglial cells, LC3-positive bacterium-containing
phagolysosomes have been shown to fuse with the cytoplasmic
membrane and release their contents into the medium (45).
Moreover, ATG5-dependent fusion of lysosomes with the plasma
membrane has also been observed in osteoclasts (7). Along with
our data, these studies with other types of autophagy-dependent
exocytosis may help provide an understanding of the mechanism
by which C. neoformans nonlytic exocytosis occurs.
After demonstrating these effects of autophagy on the interac-
tions of macrophages with two fungi, we used ATG5-conditional-
knockout mice to study the physiological role of autophagy during
experimental C. albicans and C. neoformans infections. In the first
experiment, we infected these mice with the two fungi and com-
pared their survival with that of the controls. With intravenous C.
albicans infection, the results were consistent with those observed
in vitro: median survival of 6 days for conditional-knockout mice
and 10 days for controls. This result demonstrates that antifungal
autophagy is also important in vivo. In contrast, multiple experi-
ments with C. neoformans using different inocula and routes of
infection in mice of different ages and sexes showed no difference
in survival rates. This result is not very surprising, bearing in mind
that the in vitro results point to a balance of decreased macrophage
fungistatic activity on the one hand and decreased nonlytic exo-
cytosis plus increased secretion of proinflammatory IL-6 on the
other hand. To better understand how cryptococcosis developed
in mice in which macrophages lack autophagy, we used these mice
in fungal burden, histopathology, IHC, and cytokine dosing ex-
periments. While the control mice developed an intense pneumo-
nia with large neutrophilic infiltrates and early alternative activa-
tion of macrophages, the conditional-knockout mice developed a
less intense pneumonia and later alternative activation. These re-
sults suggest that mice that lack autophagy mount an altogether
different immune response to C. neoformans infection.
The results presented here suggest that macrophage autophagy
is involved in several steps in the interaction of these cells with two
different fungal pathogens, C. neoformans and C. albicans. This
reinforces the importance of immunological autophagy, which is
involved in the response to an ever increasing number of mi-
crobes. As autophagy is involved in various other neoplastic,
neurodegenerative, and autoimmune diseases (26), it is a prime
pharmacological target. Our work suggests that autophagy-mod-
ulating drugs could also be used to improve antifungal therapy.
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